In-vitro and in-vivo models for hepatitis B cure research - Institut Pasteur Access content directly
Journal Articles Current Opinion in HIV and AIDS Year : 2020

In-vitro and in-vivo models for hepatitis B cure research

Abstract

Antiviral therapy for chronic hepatitis B infection is rarely curative, thus research in HBV cure strategies is a priority. Drug development and testing has been hampered by the lack of robust cell culture systems and small animal models. This review summarizes existing models for HBV cure research and focuses on recent developments since 2017 until today.

Domains

Virology
No file

Dates and versions

pasteur-02875586 , version 1 (19-06-2020)

Identifiers

Cite

Lena Allweiss, Helene Strick-Marchand. In-vitro and in-vivo models for hepatitis B cure research. Current Opinion in HIV and AIDS, 2020, 15 (3), pp.173-179. ⟨10.1097/COH.0000000000000616⟩. ⟨pasteur-02875586⟩

Collections

PASTEUR ATP-IMMUN
43 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More